Ambulatory management of chronic hypertension in pregnancy

Clinical Obstetrics and Gynecology

Volumn 55, Issue 3, 2012, Pages 744-755

  Ames, Mary ^a   Rueda, Jose ^a   Caughey, Aaron B ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

chronic hypertension in pregnancy; essential hypertension; preterm delivery; secondary hypertension; small for gestational; superimposed pre eclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROCHLOROTHIAZIDE; LABETALOL; METHYLDOPA; NIFEDIPINE;

AMBULATORY CARE; ARTICLE; CHRONIC HYPERTENSION IN PREGNANCY; DELIVERY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECLAMPSIA; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LONG TERM CARE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MATERNAL WELFARE; MILD CHRONIC HYPERTENSION; NERVE ENDING; NERVE INJURY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PREECLAMPSIA; PREMATURE LABOR; STILLBIRTH; SUPERIMPOSED PREECLAMPSIA;

AMBULATORY CARE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; ASPIRIN; DISEASE MANAGEMENT; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84864397090     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31825c8bcd     Document Type: Article

References (34)

1. National Center for Health Statistics Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, MD: U.S Government Printing Office; 2011. p. 67.
2. National Center for Health Statistics Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, MD: U.S Government Printing Office; 2011. p. 76.
3. National Center for Health Statistics Health, United States, 2010: With Special Feature on Death and Dying. Hyattsville, MD: U.S Government Printing Office; 2011. p. 66.
4. Martin J, Hamilton B, Ventura S, Births: final data for 2009. NVSS 60; November 2011: page 9-10. Available at: www.cdc.gov/nchs/data/nvsr/nvsr60/ nvsr60-01.pdf. Accessed May 21, 2012.
5. Berg C, Callaghan W, Syverson C, et al. Pregnancy-related mortality in the United States, 1998-2005. Obstet Gynecol. 2010;116:1302-1309.
6. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
7. American College of Obstetricians and Gyneco-logistsChronic Hypertension in Pregnancy. ACOG Practice Bulletin No. 29. Washington, DC: American College of Obstetricians and Gynecologists; 2001.
8. Mulrow CD, Chiquette E, Ferrer RL, et al. Management of Chronic Hypertension During Pregnancy. Evidence Report/Technology Assessment No. 14 (Prepared by the San Antonio Evidence-based Practice Center Based at the University of Texas Health Science Center at San Antonio Under Contract No. 290-97-0012). AHRQ Publication No. 00-E011. Rockville, MD: Agency for Healthcare Research and Quality; 2000.
9. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002;100:369-377. (Pubitemid 34874806)
10. Chappell L, Enye S, Seed P, et al. Adverse perinatal outcomes and risk factors for preeclampsia in woman with chronic hypertension: a prospective study. Hypertension. 2008;51:1002-1009. (Pubitemid 351398985)
11. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med. 1998;339:667-671. (Pubitemid 28402091)
12. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol. 1986;67:517-522. (Pubitemid 16116269)
13. Manger WM. The vagaries of pheochromocyto-ma. Am J Hypertension. 2005;18:1266-1270.
14. Escher G, Cristiano M, Cauvesic M, et al. Aldos-terone to renin variants of CYP11B2 and pregnancy outcome. Nephrol Dial Transplant. 2009;
15. Cote AM, Brown MA, Lam E, et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. BMJ. 2008;336:1003-1006. (Pubitemid 351656092)
16. Lim KH, Friedman SA, Ecker JL, et al. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Ob-stet Gynecol. 1998;178:1067-1071. (Pubitemid 28247188)
17. Cooper W, Hernandez-Diaz S, Arbogast P, et al. Major congenital malformations after first-trimester exposure to ACE inhibitor. N Engl J Med. 2006;354:2443-2451. (Pubitemid 43855047)
18. Martin J, Thigpen B, Moore R, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246-254. (Pubitemid 40229437)
19. Abalos E, Duley L, Steyn DW, et al. Antihyper-tensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;CD002252.
20. von Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87-92. (Pubitemid 30068551)
21. Magee L, Elran E, Bull S, et al. Risks and benefits of b-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol. 2000;88:15-26. (Pubitemid 30009366)
22. Seedat Y. Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens. 1989;7:515-518. (Pubitemid 19189572)
23. Churchill D, Beevers GDG, Meher S, et al. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev. 2007;Issue 1. Art. No.: CD004451. doi: 10.1002/14651858.CD004451.pub2. (Pubitemid 351820429)
24. American College of Obstetricians and Gynecologists. Chronic Hypertension inPregnancy. ACOG Practice Bulletin No. 125. Washington, DC: American College of Obstetricians and Gynecologists; 2012.
25. Hutcheon J, Lisonkova S, Magee L, et al. Optimal timing of delivery in pregnancies with pre-existing hyertension. BJOG. 2011;118:49-54.
26. Caughey A, Nicholson J, Cheng Y, et al. Induction of labor and cesarean delivery by gestational age. Am J Obstet Gynecol. 2006;195:700-705. (Pubitemid 44292150)
27. Caughey A, Sundaram V, Kaimal A, et al. Elective induction of labor vs. expectant management of pregnancy: a systematic review. Ann Int Med. 2009;151:252-263.
28. Koopmans C, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multi-centre, open-label randomised controlled trial. Lancet. 2009;374:979-988.
29. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med. 1997;337:69-76. (Pubitemid 27284391)
30. Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362: 1282-1291.
31. Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;Issue 2. Art. No.: CD004659. doi: 10.1002/14651858.CD004659.pub2. (Pubitemid 351805710)
32. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 1998;338:701-705. (Pubitemid 28115087)
33. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343: 619-629.
34. Hjartardottir S, Leifsson B, Geirsson R, et al. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol. 2006;194: 916-920.